Company intelligence / Profile preview

Another Day Pharma

Sevenoaks, England, United Kingdom

Ownership: Private
Development stage: Commercial

Overview

Another Day Pharma has reported successful Phase II clinical trial results for its lead candidate BZ371A, a topical peptide gel for post-prostatectomy erectile dysfunction. The trial met its primary endpoint, showing significant improvement in erectile function either as monotherapy or combined with tadalafil. BZ371A is also being evaluated in Phase II trials for female sexual dysfunction. The therapy was well-tolerated and represents a novel non-hormonal approach to treating sexual health disorders where current options are limited or ineffective.

Therapeutic areas: Women's HealthMen's Health
Modalities: PeptidesSmall molecule (tadalafil, in combination studies)
Industry: Biotech

Drug pipeline

7 assets

dupixent

Commercial

Indications: Immunological disorders

6 more assets in the full pipeline.

Request access →

Partnerships

Biozeus Biopharmaceuticals S.A. (Brazil) – licensing/partnership agreement for development and commercialization of novel NCE BZ371A and other peptides

Beyond the preview

Go deeper on Another Day Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Another Day Pharma.

Explore the full profile